Mackay Shields LLC boosted its holdings in Huntsman Co. (NYSE:HUN) by 257.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 205,967 shares of the basic materials company’s stock after buying an additional 148,399 shares during the period. Mackay Shields LLC owned 0.09% of Huntsman worth $4,791,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of HUN. Usca Ria LLC acquired a new position in shares of Huntsman in the 3rd quarter valued at about $35,000. Gradient Investments LLC lifted its stake in shares of Huntsman by 246.3% in the 2nd quarter. Gradient Investments LLC now owns 2,635 shares of the basic materials company’s stock valued at $54,000 after purchasing an additional 1,874 shares in the last quarter. Howe & Rusling Inc. lifted its stake in shares of Huntsman by 856.2% in the 3rd quarter. Howe & Rusling Inc. now owns 2,792 shares of the basic materials company’s stock valued at $65,000 after purchasing an additional 2,500 shares in the last quarter. Oppenheimer Asset Management Inc. lifted its stake in shares of Huntsman by 54.7% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 3,566 shares of the basic materials company’s stock valued at $72,000 after purchasing an additional 1,261 shares in the last quarter. Finally, Cerebellum GP LLC acquired a new position in shares of Huntsman in the 3rd quarter valued at about $128,000. 74.43% of the stock is currently owned by hedge funds and other institutional investors.
Several research firms have recently weighed in on HUN. Citigroup lifted their price objective on Huntsman from $21.00 to $23.00 and gave the company a “neutral” rating in a research note on Wednesday, October 9th. ValuEngine raised Huntsman from a “sell” rating to a “hold” rating in a research note on Tuesday, September 10th. Barclays reaffirmed a “sell” rating and issued a $19.00 price objective on shares of Huntsman in a research note on Wednesday, July 31st. Wells Fargo & Co began coverage on Huntsman in a research note on Tuesday, October 15th. They issued an “outperform” rating and a $28.00 price objective on the stock. Finally, UBS Group lifted their price objective on Huntsman from $26.00 to $28.00 and gave the company a “buy” rating in a research note on Wednesday, October 2nd. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $26.25.
Huntsman (NYSE:HUN) last announced its earnings results on Friday, October 25th. The basic materials company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.01). The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Huntsman had a negative net margin of 0.99% and a positive return on equity of 17.06%. The business’s quarterly revenue was down 14.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.84 earnings per share. Equities research analysts expect that Huntsman Co. will post 1.53 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Friday, December 13th will be issued a dividend of $0.1625 per share. The ex-dividend date of this dividend is Thursday, December 12th. This represents a $0.65 annualized dividend and a dividend yield of 2.77%. Huntsman’s payout ratio is currently 19.46%.
Huntsman Corporation manufactures and sells differentiated organic chemical products worldwide. The company operates in four segments: Polyurethanes, Performance Products, Advanced Materials, and Textile Effects. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyols, thermoplastic polyurethane, propylene oxide, and methyl tertiary-butyl ether products.
Featured Article: How a Strangle Strategy is different from a Straddle Strategy
Want to see what other hedge funds are holding HUN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Huntsman Co. (NYSE:HUN).
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.